Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	352
Overall Study	STARTED	Montelukast 10 mg	348
Overall Study	STARTED	Loratadine 10 mg	602
Overall Study	STARTED	Montelukast/Loratadine	275
Overall Study	COMPLETED	Placebo	334
Overall Study	COMPLETED	Montelukast 10 mg	336
Overall Study	COMPLETED	Loratadine 10 mg	573
Overall Study	COMPLETED	Montelukast/Loratadine	159
Overall Study	NOT COMPLETED	Placebo	18
Overall Study	NOT COMPLETED	Montelukast 10 mg	12
Overall Study	NOT COMPLETED	Loratadine 10 mg	29
Overall Study	NOT COMPLETED	Montelukast/Loratadine	116

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00979901/flow